Just as it leads in biomedical innovation, the pharmaceutical industry is proud to play a leading role in sponsoring continuing medical education (CME) for physicians—an effort that serves the overriding mutual interest to ensure that patients receive the most up-to-date and appropriate care.
No takes yet. Share an insight, caveat, or question.
Alan F. Holmer (2001) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: